The said facility is operated by Jubilant Draximage Inc., a subsidiary of Jubilant Pharma (JPL), which is a wholly-owned subsidiary of Jubilant Pharmova. JPL is an ntegrated global pharmaceutical company engaged in manufacturing and supply of Radiopharmaceuticals with a network of 46 radio-pharmacies in the US; allergy immunotherapy, contract manufacturing of sterile injectables and non-sterile products and solid dosage formulations through five manufacturing facilities that cater to all the regulated market including USA, Europe and other geographies.

"The USFDA has issued 5 observations pursuant to the completion of audit. The company will submit an action plan on the observations," Jubilant Pharmova said in a statement.

Jubilant Pharmova is engaged in radiopharma, allergy imm...

• 

  (01-Jan-16 09:32)

  KEC International gains after winning orders
• 

  (01-Jan-16 10:10)

  Aviation stocks in demand
• 

  (01-Jan-16 10:41)

  Select stocks in demand after F&O inclusion
• 

  (01-Jan-16 10:56)

  Piramal Enterprises gains on fund raising proposal